More than two decades ago, a research team in the lab of David Hafler, a Yale researcher who at the time was at Harvard, discovered a type of T cell in humans that suppresses the immune system; they later found that these so-called regulatory T cells, when defective, are an underlying cause of autoimmune disease, specifically multiple sclerosis (MS).
Study reveals a new target for universal treatment for autoimmune diseases
- Post author:
- Post published:August 28, 2024
- Post category:uncategorized